13 completed, 6 recruiting, 6 terminated, 4 not yet recruiting. 10 Phase 1, 9 Not applicable, 5 Phase 2, 2 Phase 4.
Follow Hepatic Cancer: new trials by email Literature Review of Hepatic Cancer trials Research Report on Hepatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy Three-Dimensional Magnetic Resonance Elastography - Hepatic Cancer, Hepatocellular Carcinoma | Not yet recruiting | Second Affiliated Hospital of Xi'an Jiaotong University | 150 | 2026-08-01 | 2026-07-15 | |
| Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors EXS74539 - Solid Tumor, Small Cell Lung Cancer (SCLC) | Phase 1 | Recruiting | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 40 | 2026-04-13 | 2026-06-10 |
| Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy SCL tests, POC viscoelastic tests - Arthritis of Knee, Arthritis of Hip | Not yet recruiting | Konkuk University Medical Center | 210 | 2026-02-01 | 2025-12-08 | |
| Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis Seravue - Hepatic Cancer | Not yet recruiting | ImCare Biotech | 1392 | 2025-08-01 | 2025-06-04 | |
| Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation Intravenous esketamine using Dixon's up-and-down sequential method, Intravenous the dose of esketamine ED95, Intravenous fentanyl 1 μg∙kg-1 - Hepatic Neoplasm, Hepatic Cancer | Phase 1 / Phase 2 | Active not recruiting | The First Affiliated Hospital of Xiamen University | 79 | 2025-06-29 | 2025-09-11 |
| Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery Local Anesthesia, Laparoscopic Transversus Abdominis Plane block - Oncologic Surgery, Cancer | Not applicable | Recruiting | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 48 | 2025-02-05 | 2025-09-18 |
| Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation Immunohistochemistry and in situ hybridisation analysis - Hepatic Cancer, Hepatic Resection | Not applicable | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 100 | 2024-10-23 | 2024-12-05 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab - Hepatic Cancer, Surgery | Phase 2 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 90 | 2024-07-01 | 2024-07-09 |
| An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer ELUCIDATE - Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma | Recruiting | City of Hope Medical Center | 400 | 2024-03-15 | 2026-07-07 | |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery TXA, TEG6 - Arthritis Knee, Spine Fusion | Phase 4 | Unknown | Konkuk University Medical Center | 148 | 2024-02-10 | 2024-05-14 |
| Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC) assisted liver transplantation combined with two-stage hepatectomy - Liver Transplant Disorder, Hepatic Cancer | Not applicable | Not yet recruiting | RenJi Hospital | 30 | 2023-08-01 | 2023-08-07 |
| A Study of CDX-585 in Patients With Advanced Malignancies CDX-585 - Non-small Cell Lung Cancer, Gastric Cancer | Phase 1 | Completed | Celldex Therapeutics | 20 | 2023-05-11 | 2025-06-15 |
| Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function transarterial chemoembolisation - Hepatic Cancer | Completed | Tang-Du Hospital | 2200 | 2023-01-01 | 2024-02-07 | |
| The Registry of Oncology Outcomes Associated With Testing and Treatment Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P) - Adenocarcinoma, Adenocystic Carcinoma | Completed | Taproot Health | 167 | 2021-05-05 | 2024-12-18 | |
| Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors Chemoembolization, Chemoinfusion - Hepatic Cancer, Metastatic Cancer | Unknown | Central Clinical Hospital RZD-Medicine, Russian Federation | 500 | 2021-01-12 | 2021-02-21 | |
| Bleeding in Laparoscopic Liver Surgery Neuromuscular blockade - Neuromuscular Blockade, Intraoperative Bleeding | Not applicable | Terminated | Università Vita-Salute San Raffaele | 48 | 2020-10-30 | 2025-08-07 |
| Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy Colorectal Cancer, Pancreatic Cancer | Terminated | Centre Hospitalier de la côte Basque | 31 | 2020-10-16 | 2024-09-26 | |
| Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients 68Ga/18F-PSMA/PSFA - PSMA-related Disease, Prostate Cancer | Recruiting | Tianjin Medical University | 500 | 2020-09-01 | 2026-09-08 | |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies CDX-527 - Non-small Cell Lung Cancer, Breast Cancer | Phase 1 | Completed | Celldex Therapeutics | 27 | 2020-08-04 | 2023-06-18 |
| Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas Computed Tomography of the Abdomen - Contrast Media, Computed Tomography | Unknown | Karolinska Institutet | 50 | 2018-09-10 | 2021-03-24 |
Showing 20 of 35. Sign in to see all of them.
Liver Neoplasms (35) · Stomach Neoplasms (9) · Pancreatic Neoplasms (8) · Colorectal Neoplasms (7) · Carcinoma, Hepatocellular (6) · Carcinoma, Renal Cell (5) · Cholangiocarcinoma (5) · Esophageal Neoplasms (5) · Ovarian Neoplasms (5) · Prostatic Neoplasms (5) · Breast Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (4) · Fallopian Tube Neoplasms (4) · Head and Neck Neoplasms (4) · Neoplasms (4)
Digestive System Diseases (35) · Digestive System Neoplasms (35) · Liver Diseases (35) · Neoplasms by Site (35) · Neoplasms (31) · Neoplasms by Histologic Type (12) · Neoplasms, Glandular and Epithelial (12) · Carcinoma (11) · Adenocarcinoma (10) · Endocrine Gland Neoplasms (10) · Endocrine System Diseases (10) · Gastrointestinal Diseases (10) · Stomach Diseases (9) · Colonic Diseases (8) · Genital Diseases (8)
Drug Therapy (2) · pembrolizumab (2) · Anesthesia, Local (1) · Bevacizumab (1) · Biological Therapy (1) · Chemoembolization, Therapeutic (1) · Floxuridine (1) · Galactose (1) · H3B-6527 (1) · Idarubicin (1) · Immunohistochemistry (1) · Immunotherapy (1) · Ipilimumab (1) · Lidocaine (1) · Molecular Diagnostic Techniques (1)
Celldex Therapeutics (3) · National Institutes of Health Clinical Center (CC) (3) · Konkuk University Medical Center (2) · AdventHealth (1) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Biosplice Therapeutics, Inc. (1) · Central Clinical Hospital RZD-Medicine, Russian Federation (1) · Centre Hospitalier de la côte Basque (1) · City of Hope Medical Center (1) · Daiichi Sankyo (1) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. (1) · H3 Biomedicine Inc. (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · ImCare Biotech (1) · Karolinska Institutet (1)
United States (21) · China (4) · South Korea (4) · Italy (3) · France (2) · Japan (2) · Russia (2) · Taiwan (2) · Belgium (1) · Canada (1) · Singapore (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Bradford J Wood, M.D. (3) · Tae-Yop Kim, MD, PhD (2) · Ajay Goel, PhD (1) · Alberto Zangrillo, Prof. (1) · Casey Allen, MD (1) · Evangelos A Konstantinou, RN, PhD (1) · Francesco Vasuri, MD (1) · Heather Yeo, MD (1) · James Pingpank, MD (1) · Jason Smith, MD (1) · Jennifer Johnson, MD, PhD (1) · Katharina Brehmer, MD (1) · Lijuan Yan (1) · Luigi Beretta, Prof. (1)
PMID 26071796, PMID 29149611, PMID 41120594
2016 (1), R01CA104524 (1)